Clin2
NCT07633080Possibly a fitRecruiting

Magnesium supplement added to antidepressants for depression

Major Depressive Disorder

Part of Mental health clinical trials.

This study tests whether adding magnesium bisglycinate (a mineral supplement) to your current antidepressant medication can help improve depression symptoms. Researchers want to see if this combination works better than antidepressant alone.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with major depressive disorder
  • You are between 18 and 65 years old
  • You are currently taking a stable dose of an SSRI or SNRI antidepressant (like sertraline, escitalopram, or venlafaxine)
  • You have mild to severe depression symptoms (not just mild sadness)
  • You are willing to take magnesium bisglycinate as a daily supplement alongside your current medication

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05895747Recruiting· Phase 2
5-HTP and creatine for adults with depression symptoms

This Phase 2 study tests whether adding 5-HTP and creatine can reduce depression symptoms in adults with major depressive disorder. It may help if your current depression treatment hasn’t been fully effective and you meet the safety and medical criteria.

Salt Lake City, Utah
NCT07772531Not yet recruiting· Phase 2
BMS-986511 for major depressive disorder

This study tests an investigational drug called BMS-986511 in adults with moderate to severe depression. The goal is to see if it can improve symptoms.

Phoenix, Arizona
NCT05136755Recruiting· Phase 2
NMDA treatment for depression that did not improve

This trial studies an NMDA-based treatment for people with major depressive disorder who did not respond to at least one antidepressant. It may help by changing brain signaling linked to depression symptoms.

Taichung
NCT04637620Recruiting· Phase 2
NMDA-based treatment study for major depression

This Phase 2 trial tests whether an NMDA-targeted treatment can improve symptoms of major depressive disorder (MDD). You may be able to join if your depression diagnosis and symptom score fit, and you meet several safety and study-following requirements.

Taichung
NCT05644301Recruiting· Phase 3
Blood-marker guided add-on treatment for major depression

This study tests whether doctors can choose the best add-on immune-related treatment for people with major depressive disorder by using inflammation blood tests. It’s meant for people whose depression has not improved enough with their current antidepressant.

Duffel, Antwerpen
NCT07029607Not yet recruiting
Can magnesium supplements improve relaxation in healthy adults?

This study tests whether a magnesium supplement can help improve relaxation in healthy adults. If you join, you'll take the supplement or a placebo (no active ingredient) twice a day for a few weeks and answer questions about how you feel.

St. Petersburg, Florida

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.